annual D&A:
-$7.17M-$400.00K(-5.90%)Summary
- As of today (June 25, 2025), SPRY annual depreciation & amortization is -$7.17 million, with the most recent change of -$400.00 thousand (-5.90%) on December 31, 2024.
- During the last 3 years, SPRY annual D&A has fallen by -$7.39 million (-3468.54%).
- SPRY annual D&A is now -2349.22% below its all-time high of $319.00 thousand, reached on December 31, 2022.
Performance
SPRY Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
-$1.68M-$166.00K(-10.96%)Summary
- As of today (June 25, 2025), SPRY quarterly depreciation & amortization is -$1.68 million, with the most recent change of -$166.00 thousand (-10.96%) on March 31, 2025.
- Over the past year, SPRY quarterly D&A has increased by +$288.00 thousand (+14.63%).
- SPRY quarterly D&A is now -662.21% below its all-time high of $299.00 thousand, reached on December 31, 2022.
Performance
SPRY quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
-$6.89M+$288.00K(+4.01%)Summary
- As of today (June 25, 2025), SPRY TTM depreciation & amortization is -$6.89 million, with the most recent change of +$288.00 thousand (+4.01%) on March 31, 2025.
- Over the past year, SPRY TTM D&A has increased by +$68.00 thousand (+0.98%).
- SPRY TTM D&A is now -2258.93% below its all-time high of $319.00 thousand, reached on December 31, 2022.
Performance
SPRY TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
SPRY Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | +14.6% | +1.0% |
| 3 y3 years | -3468.5% | -3462.0% | -10000.0% |
| 5 y5 years | -10000.0% | - | - |
SPRY Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2349.2% | at low | -662.2% | +14.6% | -2258.9% | +6.6% |
| 5 y | 5-year | -2349.2% | at low | -662.2% | +14.6% | -2258.9% | +6.6% |
| alltime | all time | -2349.2% | at low | -662.2% | +14.6% | -2258.9% | +6.6% |
SPRY Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.68M(+11.0%) | -$6.89M(-4.0%) |
| Dec 2024 | -$7.17M(+5.9%) | -$1.51M(-16.1%) | -$7.17M(-2.7%) |
| Sep 2024 | - | -$1.80M(-4.3%) | -$7.38M(+3.7%) |
| Jun 2024 | - | -$1.89M(-4.2%) | -$7.11M(+2.2%) |
| Mar 2024 | - | -$1.97M(+14.8%) | -$6.96M(+2.7%) |
| Dec 2023 | -$6.78M | -$1.72M(+11.4%) | -$6.78M(+42.3%) |
| Sep 2023 | - | -$1.54M(-11.1%) | -$4.76M(+48.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$1.73M(-3.2%) | -$3.21M(+111.5%) |
| Mar 2023 | - | -$1.79M(-698.3%) | -$1.52M(-576.5%) |
| Dec 2022 | $319.00K(+49.8%) | $299.00K(+4171.4%) | $319.00K(+1495.0%) |
| Sep 2022 | - | $7000.00(-118.9%) | $20.00K(+53.8%) |
| Jun 2022 | - | -$37.00K(-174.0%) | $13.00K(-74.0%) |
| Mar 2022 | - | $50.00K | $50.00K |
| Dec 2021 | $213.00K(+3450.0%) | - | - |
| Dec 2020 | $6000.00 | - | - |
FAQ
- What is ARS Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual D&A year-on-year change?
- What is ARS Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly D&A year-on-year change?
- What is ARS Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM D&A year-on-year change?
What is ARS Pharmaceuticals annual depreciation & amortization?
The current annual D&A of SPRY is -$7.17M
What is the all time high annual D&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual depreciation & amortization is $319.00K
What is ARS Pharmaceuticals annual D&A year-on-year change?
Over the past year, SPRY annual depreciation & amortization has changed by -$400.00K (-5.90%)
What is ARS Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of SPRY is -$1.68M
What is the all time high quarterly D&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly depreciation & amortization is $299.00K
What is ARS Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, SPRY quarterly depreciation & amortization has changed by +$288.00K (+14.63%)
What is ARS Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of SPRY is -$6.89M
What is the all time high TTM D&A for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM depreciation & amortization is $319.00K
What is ARS Pharmaceuticals TTM D&A year-on-year change?
Over the past year, SPRY TTM depreciation & amortization has changed by +$68.00K (+0.98%)